[HTML][HTML] Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study

CT Turner, RK Gupta, E Tsaliki, JK Roe… - The Lancet …, 2020 - thelancet.com
Background Blood transcriptional signatures are candidates for non-sputum triage or
confirmatory tests of tuberculosis. Prospective head-to-head comparisons of their diagnostic …

[HTML][HTML] Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK

A Abbara, S Chitty, JK Roe, R Ghani, SM Collin… - BMC Infectious …, 2017 - Springer
Background We describe drug-induced liver injury (DILI) secondary to antituberculous treatment
(ATT) in a large tuberculosis (TB) centre in London; we identify the proportion who had …

[HTML][HTML] Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis

JK Roe, N Thomas, E Gil, K Best, E Tsaliki… - JCI insight, 2016 - ncbi.nlm.nih.gov
BACKGROUND. Novel rapid diagnostics for active tuberculosis (TB) are required to overcome
the time delays and inadequate sensitivity of current microbiological tests that are critically …

HIV care and the incidence of acute renal failure

J Roe, LJ Campbell, F Ibrahim… - Clinical Infectious …, 2008 - academic.oup.com
Background. The clinical epidemiology of acute renal failure (ARF) in human immunodeficiency
virus (HIV)-infected patients remains poorly defined. Methods. We conducted a …

[HTML][HTML] Diagnostic 'omics' for active tuberculosis

CT Haas, JK Roe, G Pollara, M Mehta, M Noursadeghi - BMC medicine, 2016 - Springer
The decision to treat active tuberculosis (TB) is dependent on microbiological tests for the
organism or evidence of disease compatible with TB in people with a high demographic risk of …

[HTML][HTML] Dynamic perturbations of the T-cell receptor repertoire in chronic HIV infection and following antiretroviral therapy

JM Heather, K Best, T Oakes, ER Gray, JK Roe… - Frontiers in …, 2016 - frontiersin.org
HIV infection profoundly affects many parameters of the immune system and ultimately leads
to AIDS, yet which factors are most important for determining resistance, pathology, and …

Blood transcriptomic stratification of short-term risk in contacts of tuberculosis

J Roe, C Venturini, RK Gupta, C Gurry… - Clinical Infectious …, 2020 - academic.oup.com
Background The highest risk of tuberculosis arises in the first few months after exposure.
We reasoned that this risk reflects incipient disease among tuberculosis contacts. Blood …

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients

AD Pria, D Pinato, J Roe, K Naresh… - Blood, The Journal …, 2017 - ashpublications.org
Successful treatment of HIV-associated multicentric Castleman disease (HIV+MCD) with
rituximab-based approaches has dramatically improved survival and reduced the risk of human …

[HTML][HTML] In vivo molecular dissection of the effects of HIV-1 in active tuberculosis

…, M Pascoe, GS Tomlinson, RJ Lehloenya, J Roe… - PLoS …, 2016 - journals.plos.org
Increased risk of tuberculosis (TB) associated with HIV-1 infection is primarily attributed to
deficient T helper (Th)1 immune responses, but most people with active TB have robust Th1 …

Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure

F Ibrahim, C Naftalin, E Cheserem, J Roe, LJ Campbell… - Aids, 2010 - journals.lww.com
Objective: To identify risk factors for acute renal failure (ARF) in HIV-infected patients. Design:
Observational cohort study of HIV-infected patients attending a South London HIV centre …